The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Wainzua (eplontersen) to treat adults with ...
The MHRA has introduced seven new CERSIs to modernise healthcare regulation and accelerate patient access to innovative ...
GlobalData on MSN7d
MHRA approves trofolastat for prostate cancer diagnostic imagingTrofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...
4basebio PLC has been granted Good Manufacturing Practice (GMP) certification by the UK’s Medicines and Healthcare products ...
GlobalData on MSN9d
MHRA launches new monthly safety bulletinsThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced new monthly safety bulletins aimed at making ...
News Medical on MSN2d
4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNAPLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received ...
News Medical on MSN4d
World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in menThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...
GlobalData on MSN10d
Entrada gains UK MHRA authorisation to start Phase I/II trial of DMD treatmentEntrada Therapeutics has secured authorisation from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) and ...
Seven new CERSIs came together to showcase how partnerships will modernise regulation in AI, clinical trials, and advanced therapies, bringing ...
Lawrence Tallon today (1 April 2025) begins his role as Chief Executive Officer of the Medicines and Healthcare products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback